{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T20:43:48Z","timestamp":1783802628863,"version":"3.55.0"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T00:00:00Z","timestamp":1518393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0192703","type":"journal-article","created":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T13:35:40Z","timestamp":1518442540000},"page":"e0192703","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["FAS promoter polymorphisms and serum sFas level are associated with increased risk of nerve damage in Bangladeshi patients with Guillain-Barr\u00e9 syndrome"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0935-8079","authenticated-orcid":true,"given":"Zhahirul","family":"Islam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israt","family":"Jahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rijwan U.","family":"Ahammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Shahnaij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamsun","family":"Nahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quazi D.","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,2,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.autrev.2017.02.002","article-title":"Autoimmunity in Guillain-Barre syndrome associated with Zika virus infection and beyond","volume":"16","author":"CA Pinto-Diaz","year":"2017","journal-title":"Autoimmun Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"B van den Berg","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00415-011-6330-4","article-title":"Guillain-Barre syndrome associated with normal or exaggerated tendon reflexes","volume":"259","author":"N Yuki","year":"2012","journal-title":"J Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1212\/WNL.0b013e3181cff735","article-title":"Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh","volume":"74","author":"Z Islam","year":"2010","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e43976","DOI":"10.1371\/journal.pone.0043976","article-title":"Guillain-Barre syndrome-related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies","volume":"7","author":"Z Islam","year":"2012","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.it.2003.12.004","article-title":"The Guillain-Barre syndrome: a true case of molecular mimicry","volume":"25","author":"CW Ang","year":"2004","journal-title":"Trends Immunol"},{"key":"ref7","first-page":"9","article-title":"Epidemiology of Campylobacter-Jejuni Infections in the United-States and Other Industrialized Nations","author":"RV Tauxe","year":"1992","journal-title":"Camplylobacter Jejuni"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/504294","article-title":"Incidence of Guillain-Barr\u00e9 syndrome among patients with Campylobacter infection: a general practice research database study","volume":"194","author":"CC Tam","year":"2006","journal-title":"The Journal of infectious diseases"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3389\/fimmu.2017.00403","article-title":"Dual Role of Fas\/FasL-Mediated Signal in Peripheral Immune Tolerance","volume":"8","author":"A Yamada","year":"2017","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1744-313X.2007.00676.x","article-title":"A polymorphism in FAS gene promoter correlated with circulating soluble FAS levels","volume":"34","author":"W Mahfoudh","year":"2007","journal-title":"Int J Immunogenet"},{"key":"ref11","first-page":"1183","article-title":"A functional polymorphism in fas (CD95\/APO-1) gene promoter associated with systemic lupus erythematosus","volume":"29","author":"S Kanemitsu","year":"2002","journal-title":"J Rheumatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/08820130903401736","article-title":"Fas Gene Polymorphisms in Systemic Lupus Erythematosus and Serum Levels of Some Apoptosis-Related Molecules","volume":"39","author":"JM Araste","year":"2010","journal-title":"Immunological Investigations"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-5728(02)00163-7","article-title":"The FAS-670 polymorphism influences susceptibility to multiple sclerosis","volume":"128","author":"T van Veen","year":"2002","journal-title":"J Neuroimmunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/ard.2003.006056","article-title":"Fas gene promoter polymorphisms in primary Sjogren\u2019s syndrome","volume":"63","author":"CG Mullighan","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jneuroim.2004.12.001","article-title":"Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain-Barre syndrome","volume":"161","author":"K Geleijns","year":"2005","journal-title":"J Neuroimmunol"},{"key":"ref16","first-page":"3529","article-title":"Circulating soluble Fas concentration in breast cancer patients","volume":"5","author":"T Ueno","year":"1999","journal-title":"Clin Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1191\/096120300678828145","article-title":"Serum levels of soluble Fas correlate with indices of organ damage in systemic lupus erythematosus","volume":"9","author":"MH Al-Maini","year":"2000","journal-title":"Lupus"},{"key":"ref18","first-page":"5981432","article-title":"A Potential of sFasL in Preventing Gland Injury in Sjogren\u2019s Syndrome","volume":"2017","author":"J Luo","year":"2017","journal-title":"Biomed Res Int"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00403-005-0616-2","article-title":"Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese","volume":"297","author":"JH Hao","year":"2006","journal-title":"Archives of Dermatological Research"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/S0002-9440(10)65434-X","article-title":"Alterations of Fas (Apo-1\/CD95) gene in cutaneous malignant melanoma","volume":"154","author":"MS Shin","year":"1999","journal-title":"Am J Pathol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/jns.12215","article-title":"High mortality from Guillain-Barre syndrome in Bangladesh","volume":"22","author":"T Ishaque","year":"2017","journal-title":"J Peripher Nerv Syst"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/jns.12189","article-title":"Guillain-Barre syndrome in Bangladesh: validation of Brighton criteria","volume":"21","author":"MB Islam","year":"2016","journal-title":"J Peripher Nerv Syst"},{"issue":"Suppl","key":"ref23","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barre syndrome","volume":"27","author":"AK Asbury","year":"1990","journal-title":"Ann Neurol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jns.2005.07.009","article-title":"Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA","volume":"239","author":"ML Kuijf","year":"2005","journal-title":"Journal of the neurological sciences"},{"key":"ref25","first-page":"2397","article-title":"Fas and Fas ligand gene polymorphisms in primary Sj\u00f6gren\u2019s syndrome","volume":"27","author":"AI Bolstad","year":"2000","journal-title":"The Journal of rheumatology"},{"key":"ref26","first-page":"2008","article-title":"Fas promoter-670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus","volume":"28","author":"YH Lee","year":"2001","journal-title":"The Journal of rheumatology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-5728(02)00163-7","article-title":"The FAS\u2212 670 polymorphism influences susceptibility to multiple sclerosis","volume":"128","author":"T Van Veen","year":"2002","journal-title":"Journal of neuroimmunology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/(SICI)1098-1136(200006)30:4<373::AID-GLIA60>3.0.CO;2-#","article-title":"Regulation of Fas and FasL expression on rat Schwann cells","volume":"30","author":"G Wohlleben","year":"2000","journal-title":"Glia"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1023\/A:1026113222478","article-title":"Fas-beyond death: a regenerative role for Fas in the nervous system","volume":"8","author":"C Lambert","year":"2003","journal-title":"Apoptosis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3201\/eid1707.101999","article-title":"High incidence of Guillain-Barre syndrome in children, Bangladesh","volume":"17","author":"Z Islam","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-3835(95)03834-J","article-title":"Soluble Fas\/APO-1 in tumor cells: a potential regulator of apoptosis?","volume":"94","author":"LB Owen-Schaub","year":"1995","journal-title":"Cancer Lett"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0192703","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:52:36Z","timestamp":1540342356000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0192703"}},"subtitle":[],"editor":[{"given":"Mohammad O","family":"Hoque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,2,12]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0192703","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,12]]}}}